Home       Privacy       Archive       Realtime Report



Stock Trading History of Kelly Thomas Patrick

The following table details the trading activities (stock purchases, stock sales, and stock option exercises) reported to the Securities and Exchange Commission (SEC) by insider Kelly Thomas Patrick since year 2005. The trader's CIK number is 1410514. At the time of this reporting, Kelly Thomas Patrick is the CFO & SVP Finance & Corp. Dev, of Critical Therapeutics Inc (stock ticker symbol CRTX).

Stock purchases, sales, and option exercises reported by Kelly Thomas Patrick since 2005.
  Trade Date   Symbol Company Name (Issuer) Trade Type     Shares       Price ($)   Value ($)
2007-08-22 CRTX Critical Therapeutics Inc Purchase 4,000 2.08 8,319

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Kelly Thomas Patrick (CFO & SVP Finance & Corp. Dev, of Critical Therapeutics Inc at the time of this reporting) see the Securities and Exchange Commission (SEC) website.

© 2005-2008, insider-monitor.com. All rights reserved.